Antibiotic stewardship-more education and regulation not more availability?

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 5, 2009, Pages

  Dryden, Matthew S ^a   Cooke, Jonathan ^b   Davey, Peter ^c  

^a ROYAL HAMPSHIRE COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Division of Clinical and Population Sciences and Education   (United Kingdom)

Author keywords

Antibiotic resistance; Nitrofurantoin; Over the counter; Prescribing; Trimethoprim

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; METICILLIN; NITROFURANTOIN; NON PRESCRIPTION DRUG; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CLINICAL PRACTICE; CONTINUING EDUCATION; DRUG CLASSIFICATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG USE; ESCHERICHIA COLI; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH EDUCATION; HUMAN; INFORMATION DISSEMINATION; MEDICAL INFORMATION; MEDICAL SOCIETY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT DECISION MAKING; PATIENT EDUCATION; PATIENT SAFETY; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; SELF MEDICATION; UNITED KINGDOM; URINARY TRACT INFECTION; DRUG UTILIZATION; MEDICAL EDUCATION; METHODOLOGY; STANDARD;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG UTILIZATION; EDUCATION, MEDICAL, CONTINUING; GREAT BRITAIN; HEALTH POLICY; HUMANS;

EID: 73949140517     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp305     Document Type: Article

References (32)

1. Wise R, Hart T, Cars O et al. Antibiotic resistance. BMJ 1998; 317; 609-10.
2. Standing Medical Advisory Committee, Sub-Group on Antimicrobial Resistance. The Path of Least Resistance. London: Department of Health, 1998.
3. Department of Health. Winning ways: working together to reduce healthcare associated infection in England. 2003. www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyA ndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4064682 &chk=Vqjhyn (29 July 2009, date last accessed).
4. Chief Medical Officer's Report 2008. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/AnnualRep orts/DH_096206. (23 July 2009, date last accessed).
5. Reeves DS, Finch RG, Bax RP et al. Self-medication of antibacterials without prescription (also called 'over-the-counter' use): a report of a Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 1999; 44: 163-77.
6. Kahlmeter G, Cars O. Pan-European comparison of non-hospital antibiotic use and resistance in community E. coli. In: Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy Chicago, 2001. Abstract C2-1862, p. 136. American Society for Microbiology, Washington, DC, USA.
7. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.
8. Reeves D. The 2005 Garrod Lecture: The changing access of patients to antibiotics - for better or worse? J Antimicrob Chemother 2007; 59: 333-41.
9. Saving Lives: reducing infection, delivering clean and safe care. 2007. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/Publicati onsPolicyAndGuidance/DH_078134 (24 July 2009, date last accessed).
10. Finch R, Sharland M. 18 November and beyond: observations on the EU Antibiotic Awareness Day. J Antimicrob Chemother 2009; 63: 633-5.
11. Wise R. An overview of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR). J Antimicrob Chemother 2007; 60 Suppl 1: i5-7.
12. Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection. http://www.dh.gov.uk/ab/ARHAI/index.htm (23 July 2009, date last accessed).
13. Finch RG, Garner S. Increasing access to medicines. BMJ 2009; 338: b1397.
14. Woodhead M, Finch R. Public education-a progress report. J Antimicrob Chemother 2007; 60 Suppl 1: i53-5.
15. McNulty CAM, Johnson AP. The European Antibiotic Awareness Day. J Antimicrob Chemother 2008; 62: 853-4.
16. Department of Health. The Health Act 2006: Code of practice for the prevention and control of healthcare associated infections. 2006. www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyA ndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4139336 &chk=6oAPfi (23 July 2009, date last accessed).
17. Chisholm SA, Neal TJ, Alawattegama AB et al. Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J Antimicrob Chemother 2009; 64: 353-8.
18. Royal Pharmaceutical Society. Response to the Drug and Therapeutics Bulletin Survey on Government moves to make more prescription drugs available over the counter. January 2009. http://www.rpsgb.org.uk/pdfs/pr090115.pdf (23 July 2009, date last accessed).
19. Howe RA. Over the counter medicines. Don't include trimethoprim. BMJ 2008; 336: 787.
20. Klevens RM, Morrison MA, Nadle J et al. Invasive methicillinresistant Staphylococcus aureus infections in the United States. JAMA 2007; 298: 1763-71.
21. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 2007; 298: 1772-8.
22. Mayor S. Antibiotic resistance is highest in south and east Europe. BMJ 2005; 330: 383.
23. Grigoryan L, Haaijer-Ruskamp FM, Burgerhof JGM et al. Self-medication with antimicrobial drugs in Europe. Emerg Infect Dis 2006; 12: 452-9.
24. Grigoryan L, Burgerhof JG, Degener JE et al. Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system. J Antimicrob Chemother 2008; 61: 1172-9.
25. Mitsi G, Jelastopulu E, Basiaris H et al. Patterns of antibiotic use among adults and parents in the community: a questionnaire-based survey in a Greek urban population. Int J Antimicrob Agents 2005; 25: 439-43.
26. Mainous AG III, Cheng AY, Garr RC et al. Nonprescribed antimicrobial drugs in Latino community, South Carolina. Emerg Infect Dis 2005; 11: 883-8.
27. Richman PB, Garra G, Eskin B et al. Oral antibiotic use without consulting a physician: a survey of ED patients. Am J Emerg Med 2001; 19: 57-60.
28. McKee MD, Mills L, Mainous AG III. Antibiotic use for the treatment of upper respiratory infections in a diverse community. J Fam Pract 1999; 48: 993-6.
29. Vanden Eng J, Marcus R, Hadler JL et al. Consumer attitudes and use of antibiotics. Emerg Infect Dis 2003; 9: 1128-35.
30. Guillemot D, Carbon C, Balkau B et al. Low dosage and long treatment duration of b-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998; 279: 365-70.
31. Lord Soulsby. Antimicrobials and animal health: a fascinating nexus. J Antimicrob Chemother 2007; 60 Suppl 1: i77-8.
32. McMurdo MET, Argo I, Phillips G et al. Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women. J Antimicrob Chemother 2009; 63: 389 95.